Overview
Shali Yu practices practicing medicine in China.
Her clinical expertise encompasses Lung Adenocarcinoma, Non-Alcoholic Fatty Liver Disease, and Neurotoxicity Syndromes.
She is actively involved in clinical research, co-authoring 43 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Shali Yu
Is Shali Yu a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Shali Yu is classified as an Experienced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Shali Yu participate in research or clinical trials?
Yes. Shali Yu has published 43 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Shali Yu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Lung AdenocarcinomaMs. Yu isExperienced. Learn about Lung Adenocarcinoma.
- Neurotoxicity SyndromesMs. Yu isExperienced. Learn about Neurotoxicity Syndromes.
- Non-Alcoholic Fatty Liver Disease